Welcome back to Action Potential, join us this week as we welcome Bill Van Antwerp, Founder and CSO at Laxmi, a leading expert in diabetes care.

What you'll get from this episode:

• Trailblazing in Remote Physiological Monitoring: Bill Van Antwerp shares his extensive experience in developing insulin pumps and the first FDA-approved CGM (Continuous Glucose Monitor), paving the way for modern diabetes care.
• Innovative Solutions Overcoming Manufacturing Challenges: Van Antwerp discusses the complex journey from concept to mass production, highlighting the difficulty in manufacturing reliable, consistent sensors at scale.
• The Evolution of CGM Technology: He reflects on the evolution of CGM, from initial skepticism and regulatory hurdles to its current status as a standard care tool for managing diabetes.
• Patient Empowerment through Technology: Van Antwerp emphasizes how CGMs have empowered patients, particularly in making informed decisions based on real-time data, a significant shift from the earlier FDA restrictions.
• Future Directions in Sensor Technology: Looking ahead, Van Antwerp discusses the potential of non-invasive methods and the importance of directly measuring targeted analytes for accurate and clinically actionable data.

Thank you to our sponsor ProtonIntel: “At ProtonIntel, we are building the first real-time, continuous potassium monitoring wearable, allowing clinicians to treat and manage kidney disease patients more safely and precisely. Life-saving treatments that cannot be deployed when patients have dangerous K+ levels today will be unlocked for safe and optimal use."

Learn more about Bill Van Antwerp: https://www.linkedin.com/in/bill-van-antwerp-35848052/

Follow Action Potential: https://www.linkedin.com/company/action-potential-podcast/about/

This show is part of the Slice of Healthcare podcast network: https://www.linkedin.com/company/sliceofhealthcare/